BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

402 related articles for article (PubMed ID: 19589910)

  • 1. Human aortic smooth muscle cells are insulin resistant at the receptor level but sensitive to IGF1 and IGF2.
    Chisalita SI; Johansson GS; Liefvendahl E; Bäck K; Arnqvist HJ
    J Mol Endocrinol; 2009 Dec; 43(6):231-9. PubMed ID: 19589910
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Insulin and IGF-I action on insulin receptors, IGF-I receptors, and hybrid insulin/IGF-I receptors in vascular smooth muscle cells.
    Johansson GS; Arnqvist HJ
    Am J Physiol Endocrinol Metab; 2006 Nov; 291(5):E1124-30. PubMed ID: 16803852
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insulin-like growth factor I receptors are more abundant than insulin receptors in human micro- and macrovascular endothelial cells.
    Chisalita SI; Arnqvist HJ
    Am J Physiol Endocrinol Metab; 2004 Jun; 286(6):E896-901. PubMed ID: 14722023
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterisation of receptors for IGF-I and insulin; evidence for hybrid insulin/IGF-I receptor in human coronary artery endothelial cells.
    Chisalita SI; Nitert MD; Arnqvist HJ
    Growth Horm IGF Res; 2006 Aug; 16(4):258-66. PubMed ID: 16914341
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insulin and IGF1 receptors in human cardiac microvascular endothelial cells: metabolic, mitogenic and anti-inflammatory effects.
    Bäck K; Islam R; Johansson GS; Chisalita SI; Arnqvist HJ
    J Endocrinol; 2012 Oct; 215(1):89-96. PubMed ID: 22825921
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human microvascular endothelial cells are sensitive to IGF-I but resistant to insulin at the receptor level.
    Johansson GS; Chisalita SI; Arnqvist HJ
    Mol Cell Endocrinol; 2008 Dec; 296(1-2):58-63. PubMed ID: 18708119
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Implication of insulin receptor A isoform and IRA/IGF-IR hybrid receptors in the aortic vascular smooth muscle cell proliferation: role of TNF-α and IGF-II.
    Gómez-Hernández A; Escribano Ó; Perdomo L; Otero YF; García-Gómez G; Fernández S; Beneit N; Benito M
    Endocrinology; 2013 Jul; 154(7):2352-64. PubMed ID: 23677929
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insulin-like growth factor (IGF) 2 stimulates steroidogenesis and mitosis of bovine granulosa cells through the IGF1 receptor: role of follicle-stimulating hormone and IGF2 receptor.
    Spicer LJ; Aad PY
    Biol Reprod; 2007 Jul; 77(1):18-27. PubMed ID: 17360960
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effects of puerarin on proliferation of vascular smooth muscle cells induced by thrombin].
    Xu YZ; Wang NF; Li PZ; Wu X; Ling F; Zhang XW
    Zhonghua Yi Xue Za Zhi; 2006 Feb; 86(7):476-80. PubMed ID: 16677576
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Down-regulation of type I insulin-like growth factor receptor increases sensitivity of breast cancer cells to insulin.
    Zhang H; Pelzer AM; Kiang DT; Yee D
    Cancer Res; 2007 Jan; 67(1):391-7. PubMed ID: 17210722
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential expression of alternatively spliced mRNA forms of the insulin-like growth factor 1 receptor in human neuroendocrine tumors.
    Vitale L; Lenzi L; Huntsman SA; Canaider S; Frabetti F; Casadei R; Facchin F; Carinci P; Zannotti M; Coppola D; Strippoli P
    Oncol Rep; 2006 May; 15(5):1249-56. PubMed ID: 16596194
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression and function of receptors for insulin-like growth factor-I and insulin in human coronary artery smooth muscle cells.
    Chisalita SI; Arnqvist HJ
    Diabetologia; 2005 Oct; 48(10):2155-61. PubMed ID: 16094530
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of insulin receptor (IR) A and B isoforms, IGF-IR, and IR/IGF-IR hybrid receptors in vascular smooth muscle cells and their role in cell migration in atherosclerosis.
    Beneit N; Fernández-García CE; Martín-Ventura JL; Perdomo L; Escribano Ó; Michel JB; García-Gómez G; Fernández S; Díaz-Castroverde S; Egido J; Gómez-Hernández A; Benito M
    Cardiovasc Diabetol; 2016 Dec; 15(1):161. PubMed ID: 27905925
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of constitutive IGF1/IGF2 stimulation on the transcriptional program of human breast cancer cells.
    Pacher M; Seewald MJ; Mikula M; Oehler S; Mogg M; Vinatzer U; Eger A; Schweifer N; Varecka R; Sommergruber W; Mikulits W; Schreiber M
    Carcinogenesis; 2007 Jan; 28(1):49-59. PubMed ID: 16774935
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insulin receptor and IGF1R are not required for oocyte growth, differentiation, and maturation in mice.
    Pitetti JL; Torre D; Conne B; Papaioannou MD; Cederroth CR; Xuan S; Kahn R; Parada LF; Vassalli JD; Efstratiadis A; Nef S
    Sex Dev; 2009; 3(5):264-72. PubMed ID: 19851056
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oxidative stress regulates IGF1R expression in vascular smooth-muscle cells via p53 and HDAC recruitment.
    Kavurma MM; Figg N; Bennett MR; Mercer J; Khachigian LM; Littlewood TD
    Biochem J; 2007 Oct; 407(1):79-87. PubMed ID: 17600529
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Monitoring the activation state of the insulin-like growth factor-1 receptor and its interaction with protein tyrosine phosphatase 1B using bioluminescence resonance energy transfer.
    Blanquart C; Boute N; Lacasa D; Issad T
    Mol Pharmacol; 2005 Sep; 68(3):885-94. PubMed ID: 15976035
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of hyperglycemia on the differential expression of insulin and insulin-like growth factor-I receptors in human normal peritoneal and adhesion fibroblasts.
    Rizk NN; Saed GM; Diamond MP
    Fertil Steril; 2006 Oct; 86(4 Suppl):1217-22. PubMed ID: 16962112
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanisms of disease: metabolic effects of growth hormone and insulin-like growth factor 1.
    LeRoith D; Yakar S
    Nat Clin Pract Endocrinol Metab; 2007 Mar; 3(3):302-10. PubMed ID: 17315038
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A chimeric humanized single-chain antibody against the type I insulin-like growth factor (IGF) receptor renders breast cancer cells refractory to the mitogenic effects of IGF-I.
    Sachdev D; Li SL; Hartell JS; Fujita-Yamaguchi Y; Miller JS; Yee D
    Cancer Res; 2003 Feb; 63(3):627-35. PubMed ID: 12566306
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.